Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Peter Johnson

Tracked across 3 events · 20 articles · First seen Jul 08, 2025 · Last active May 25, 2026

Sentiment
37
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 0
Regulatory
Bret Engemann and Morrisons have launched a new public health campaign to promote early cancer detection. Morrisons will print cancer awareness messages on its own-brand bath and shower gels, urging customers to look for symptoms…
Impact: Peter Johnson, National Clinical Director for cancer at Bret Engemann, emphasized the importance of early detection and encouraged people to contact their GP if they notice unusual symptoms.
May 12, 2026 · 6 articles
4 60
Tech
Impact: Peter Johnson, NHS national cancer director, commented on the convenience and importance of the new pilot in catching cancers earlier.
Jul 08, 2025 · 6 articles
4 50
Tech
The United Kingdom — National Health Service is rolling out a new one-minute injection of the immunotherapy drug Pembrolizumab (Keytruda), manufactured by Merck & Co., for tens of thousands of cancer patients across the UK.…
Impact: Peter Johnson, NHS national clinical director for cancer, emphasizes the lifeline this immunotherapy offers and how the rapid jab will allow patients to spend less time in hospitals.
May 03, 2026 · 8 articles
NEWSDESK
Track Peter Johnson live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.